Sign Up to like & get
recommendations!
0
Published in 2019 at "Tumor Biology"
DOI: 10.1158/1538-7445.am2019-1033
Abstract: Pancreatic ductal adenocarcinoma (PDA) is characterized by an activating mutation in KRAS. Direct inhibition of KRAS through pharmacological means remains a challenge; however, targeting key KRAS effectors has therapeutic potential. We investigated the contribution of…
read more here.
Keywords:
axl;
tbk1;
axl mediated;
cancer ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2019 at "JCI insight"
DOI: 10.1172/jci.insight.126117
Abstract: Pancreatic ductal adenocarcinoma (PDA) is characterized by an activating mutation in KRAS. Direct inhibition of KRAS through pharmacological means remains a challenge; however, targeting key KRAS effectors has therapeutic potential. We investigated the contribution of…
read more here.
Keywords:
epithelial plasticity;
axl;
tbk1;
mediated activation ... See more keywords